Vivo Ventures Fund V, L.P. insider trades: Soleno Therapeutics (SLNO) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Vivo Ventures Fund V, L.P. reports to the SEC
Open-market buys and sales
18 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Dec 2, 2019 | SLNO | ↓ Sell | 34,028 | $1.62 | $55K | Indirect | Dec 3, 2019 (1d) |
| Nov 27, 2019 | SLNO | ↓ Sell | 18,069 | $1.55 | $28K | Indirect | Nov 27, 2019 (0d) |
| Nov 25, 2019 | SLNO | ↓ Sell | 61,671 | $1.55 | $96K | Indirect | Nov 25, 2019 (0d) |
| Nov 20, 2019 | SLNO | ↓ Sell | 41,629 | $1.55 | $65K | Indirect | Nov 20, 2019 (0d) |
| Nov 15, 2019 | SLNO | ↓ Sell | 97,024 | $1.55 | $150K | Indirect | Nov 15, 2019 (0d) |
| Nov 5, 2019 | SLNO | ↓ Sell | 8,764 | $1.55 | $14K | Indirect | Nov 7, 2019 (2d) |
| Nov 4, 2019 | SLNO | ↓ Sell | 334,417 | $1.57 | $525K | Indirect | Nov 4, 2019 (0d) |
| Oct 28, 2019 | SLNO | ↓ Sell | 30,547 | $1.59 | $49K | Indirect | Oct 28, 2019 (0d) |
| Dec 15, 2017 | SLNO | ↑ Buy | 1,085,480 | $1.84 | $2.0M | Indirect | Dec 19, 2017 (4d) |
| Mar 7, 2017 | CAPN | ↑ Buy | 1,410,461 | $0.96 | $1.4M | Indirect | Mar 9, 2017 (2d) |
| Apr 21, 2016 | SGNT | ↓ Sell | 2,005 | $13.55 | $27K | Indirect | Apr 25, 2016 (4d) |
| Nov 4, 2015 | SGNT | ↓ Sell | 603,177 | $15.72 | $9.5M | Indirect | Nov 4, 2015 (0d) |
| Oct 29, 2013 | MEIP | ↓ Sell | 17,407 | $8.21 | $143K | Indirect | Oct 29, 2013 (0d) |
| Oct 2, 2013 | MEIP | ↓ Sell | 33,794 | $10.16 | $344K | Indirect | Oct 3, 2013 (1d) |
| Sep 16, 2013 | SGNT | ↓ Sell | 539,017 | $21.25 | $11.5M | Indirect | Sep 17, 2013 (1d) |
| Jun 28, 2013 | MEIP | ↓ Sell | 426 | $7.58 | $3K | Indirect | Jul 2, 2013 (4d) |
| Jun 11, 2013 | MEIP | ↓ Sell | 13,727 | $7.80 | $107K | Indirect | Jun 13, 2013 (2d) |
| May 16, 2013 | MEIP | ↓ Sell | 1,012 | $9.07 | $9K | Indirect | May 20, 2013 (4d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other SLNO insiders
Open-market trades in the last 12 months
About Vivo Ventures Fund V, L.P.'s insider trades
Vivo Ventures Fund V, L.P. is a 10% owner of Soleno Therapeutics (SLNO). Since May 16, 2013, it has reported 2 open-market purchases worth $3.4M and 16 sales worth $22.6M on SEC Form 4. There have been no open-market trades in the last 12 months.
Its filings also include other transactions (10 filings), conversions (2 filings), grants and awards (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every SLNO insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.